GlaxoSmithKline Pharmaceuticals Ltd.

NSE: GLAXO | BSE: 500660 | ISIN: INE159A01016 | Industry: Pharmaceuticals
| Falling Comet
2460.7000 -3.60 (-0.15%)
NSE Dec 29, 2025 12:03 PM
Volume: 31,219
 

logo
GlaxoSmithKline Pharmaceuticals Ltd.
02 Aug 2025
2460.70
-0.15%
buy
by Motilal Oswal
Target: 3000 | Upside : 21.9%
Motilal Oswal
GlaxoSmithKline Pharmaceuticals (GLXO) delivered lower-than-expected revenue/EBITDA (8%/5% miss) in 1QFY26.
 
Number of FII/FPI investors decreased from 390 to 362 in Sep 2025 qtr
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended
Market trades lower, L&T bags orders worth over Rs 2,500 crore
Trendlyne Marketwatch | 29 Dec 2025, 12:04PM
Five Interesting Stocks Today - December 26, 2025
The Baseline | 26 Dec 2025
Nifty 50 in 2025: A market hit by policy and trade pressures
The Baseline | 24 Dec 2025